Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.24K Hold
547
﹤0.01% 3340
2026
Q1
$9.36K Buy
547
+357
+188% +$6.63K ﹤0.01% 3322
2025
Q4
$3.85K Buy
+190
New +$4.12K ﹤0.01% 3026
2023
Q3
Sell
-32,205
Closed -$358K 2691
2023
Q2
$358K Hold
32,205
﹤0.01% 2421
2023
Q1
$358K Sell
32,205
-21,845
-40% -$211K ﹤0.01% 2421
2022
Q4
$537K Sell
54,050
-2,392,217
-98% -$21.6M ﹤0.01% 2152
2022
Q3
$29.2M Buy
2,446,267
+69,767
+3% +$1.5M 0.02% 671
2022
Q2
$75.4M Buy
2,376,500
+153,082
+7% +$3.94M 0.04% 449
2022
Q1
$61.3M Buy
2,223,418
+33,405
+2% +$1.19M 0.03% 567
2021
Q4
$110M Buy
2,190,013
+163,846
+8% +$7.39M 0.04% 437
2021
Q3
$72M Buy
2,026,167
+400,845
+25% +$15.9M 0.03% 538
2021
Q2
$72.2M Buy
1,625,322
+764,974
+89% +$26.1M 0.03% 530
2021
Q1
$31.4M Buy
860,348
+174,607
+25% +$7.26M 0.01% 743
2020
Q4
$29.4M Buy
685,741
+450,067
+191% +$16.5M 0.01% 749
2020
Q3
$4.73M Buy
+235,674
New +$4.61M ﹤0.01% 1167

Other funds holding XPEV

UBS AM's XPEV Position: Q2 2026 in Review

UBS AM held its XPeng (XPEV) position steady in Q2 2026 at 547 shares worth $7.24K. The position accounts for ﹤0.01% of the portfolio, ranked #3340.

UBS AM first reported a position in XPEV in Q3 2020 and has held it in 15 quarters since. The position peaked at $110M in Q4 2021. 219 funds tracked by Wall St. Rank hold XPEV as of Q2 2026.

  • UBS AM held 547 shares of XPeng worth $7.24K as of Q2 2026.
  • UBS AM left its XPeng share count unchanged in Q2 2026.
  • XPeng made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #3340 holding.
  • UBS AM first reported a position in XPeng in Q3 2020 and has held it in 15 quarters since.
  • UBS AM's XPeng position peaked at $110M in Q4 2021.
  • 219 funds tracked by Wall St. Rank held XPeng as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.